• The primary outcome measure was in-hospital mortality.

    主要评估结果住院病人死亡率。

    youdao

  • The main outcome measure was SCORing of Atopic Dermatitis (SCORAD).

    特应湿疹评分(SCORAD)主要的结果分析标准。

    youdao

  • Main Outcome Measure: Cardiac death or nonfatal myocardial infarction (MI).

    主要终点事件:心血管死亡非致死性心肌梗塞

    youdao

  • This is the primary outcome measure for the study and the data are not available yet.

    衡量研究主要指标而且数据尚未应用于实际。

    youdao

  • Main Outcome Measure: Occurrence of af during the first 84 hours after cardiac surgery.

    主要观察终点:心脏术后84小时内发生房颤

    youdao

  • The main outcome measure for adverse effects was the number of men reporting adverse effects.

    主要副作用的评估,来自不良反应报告数目

    youdao

  • Satisfaction is an outcome measure that is gaining importance as a measure of quality health care.

    满意度常常被当作评估医疗服务系统服务质量重要指标

    youdao

  • Assessment of functional ability is main item of outcome measure in patients with spinal cord injury.

    功能能力评定脊髓损伤患者功能结局评定主要项目之一。

    youdao

  • Main Outcome Measure Diopter of myopia, cornea curvature, axis length of eye and central cornea thickness.

    主要指标近视度数角膜曲率长度角膜中央厚度

    youdao

  • The primary outcome measure was the proportion of instructed and non-instructed women testing smear positive.

    主要结果评估经指导后以及进行指导后妇女检测涂片阳性结果。

    youdao

  • Admission to intensive care unit (ICU) was the secondary outcome measure and a surrogate measure of morbidity.

    次要指标入住重症监护病房(icu),将此作为发病率替代指标。

    youdao

  • MAIN OUTCOME MEASURE: the 5-ht reuptake inhibition in synaptosomes and the immobility time in depression models.

    主要观察指标突触5 -色胺重摄取抑制活性,抑郁模型小鼠静止时间

    youdao

  • The secondary outcome measure was a composite of death from cardiovascular causes and nonfatal myocardial infarction.

    次级预后终点综合心脏血管原因死亡与非致命性心肌梗塞。

    youdao

  • Main outcome measure Death from any cause or myocardial infarction or disabling stroke during a mean follow-up of 4.9 years.

    主要结局测量指标平均随访4.9年时间内所有原因死亡心肌梗死或者致残性卒中

    youdao

  • Main Outcome Measure: to evaluate the efficacy, safety, and tolerability of the octreotide implant during 24 weeks of treatment.

    主要评价指标:在24治疗期间评估评估奥曲肽植入物有效性安全性耐受性

    youdao

  • The main outcome measure was the number of reports of randomized trials identified by handsearching as compared to electronic searching.

    比较结果依据指标主要人工搜寻和电子搜寻找到随机临床试验报告数目

    youdao

  • Main Outcome Measure: The relationship between serum 25ohd, serum PTH, and serum osteocalcin and 24-h urine N-telopeptides was evaluated.

    主要观察指标血清25ohd、血清甲状旁腺激素、血清骨24小时尿n -末端肽的关系进行了评价。

    youdao

  • The primary outcome measure was progression of nephropathy, which was assessed by change in glomerular filtration rate (GFR) at 18 and 36 months.

    初级评估疗效指标肾小球过滤变化,观察18个月和36个月(3年)的肾小球滤过率(GFR)变化。

    youdao

  • MAIN OUTCOME MEASURE Discharge pattern of cells and tetrodotoxin-sensitive sodium currents under voltage-clamp configuration through I-V reaction.

    电压模式通过细胞I - V反应计算河豚毒素敏感性持续性电流大小。

    youdao

  • Main Outcome measure All measures of the primary eye care and prevention of blindness according to the criteria of the Ministry of Health of China.

    主要指标卫生部标准所规定乡村初级保健防盲的各项指标。

    youdao

  • Main Outcome Measure Availability of palliative care services in the cancer center, defined as the presence of at least 1 palliative care physician.

    主要结果测量姑息治疗癌症中心有效性定义至少1名姑息性治疗医生

    youdao

  • The main outcome measure was the area under the curve (AUC) for the increase in serum calcium from 0 to 9 hours after ingesting the test calcium source.

    主要结果量度摄入09小时血清钙浓度升高曲线面积(AUC)。

    youdao

  • MAIN OUTCOME MEASURE: proportion of patients successfully completing the 8-month course of treatment and the proportion of patients defaulting from treatment.

    主要结果检测成功完成8个月治疗疗程病人比例缺省治疗病人的比例。

    youdao

  • The primary outcome measure was the score on the modified Rankin scale (mRS) at 1 year dichotomised between favourable (0-4) and unfavourable (5 and death) outcome.

    初步测量指标1年内改良Rankin指数,分为有利0-4不利5和死亡)两部分。

    youdao

  • Main Outcome Measure For each cancer screening test, utilization rates were defined as the percentage of patients who were screened following the diagnosis of an incurable cancer.

    主要结果指标每项癌症筛查检测手段使用率定义无法治愈癌症确诊参与筛查患者百分比

    youdao

  • The primary outcome measure was a change in range of motion across 3 joints and the percentage of active over passive movements as well as changes in the Fugl-Meyer upper-extremity score.

    此项研究测量主要结果通过3个关节活动度,主动被动活动百分比以及上肢Fugl -Meyer评分等都发生改变

    youdao

  • The outcome depends in no small measure on how hard Mr. Obama is willing to battle for his policies.

    很大程度上,这个结果能否实现取决于巴马为之战斗意志有多

    youdao

  • You can use this roadmap to plan activities and projects initiated to help you adopt the best practices and to measure the adoption rates and gauge the success of the outcome.

    可以使用路线图规划开始活动项目帮助采用最佳实践评价采用率结果成功情况。

    youdao

  • Although these scoring systems provide useful information regarding many aspects of functional outcome, they are limited in their ability to measure satisfaction from the perspective of the patient.

    虽然这些评分系统提供关于很多功能结果方面有用信息但是他们测量病人术后满意度方面能力有限的。

    youdao

  • Although these scoring systems provide useful information regarding many aspects of functional outcome, they are limited in their ability to measure satisfaction from the perspective of the patient.

    虽然这些评分系统提供关于很多功能结果方面有用信息但是他们测量病人术后满意度方面能力有限的。

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定